Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
作者信息
Bendjelid Karim, Giraud Raphael, Von Düring Stephan
机构信息
Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Intensive Care Division, Geneva University Hospitals, Geneva, Switzerland; Geneva Haemodynamic Research Group, Geneva, Switzerland; Faculty of Medicine, University of Geneva, Geneva, Switzerland.
出版信息
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
Abstract
摘要
相似文献
1
Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?用烯丙哌三嗪治疗低氧血症型新冠肺炎“急性呼吸窘迫综合征”患者：越早越好？
Anaesth Crit Care Pain Med. 2020 Aug;39(4):451-452. doi: 10.1016/j.accpm.2020.07.003. Epub 2020 Jul 9.
2
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.阿米三嗪作为一种改善新冠肺炎患者肺内分流的非通气策略。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. doi: 10.1016/j.accpm.2020.05.013. Epub 2020 Jun 4.
3
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.二甲磺酸阿米三嗪与吸入一氧化氮对新型冠状病毒肺炎急性呼吸窘迫综合征氧合的影响
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.
4
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.烯丙哌三嗪治疗新型冠状病毒2型急性呼吸窘迫综合征低氧血症的疗效
Chest. 2020 Nov;158(5):2003-2006. doi: 10.1016/j.chest.2020.05.573. Epub 2020 Jun 6.
5
Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?芦可替尼对有急性呼吸窘迫综合征（ARDS）风险的新型冠状病毒肺炎（COVID-19）感染患者是否有效？
Ann Hematol. 2020 Jul;99(7):1675-1676. doi: 10.1007/s00277-020-04067-6. Epub 2020 May 14.
6
Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).氨苯砜、秋水仙碱和奥氮平作为辅助治疗药物预防新型冠状病毒肺炎相关的成人呼吸窘迫综合征（ARDS）。
Med Hypotheses. 2020 Aug;141:109774. doi: 10.1016/j.mehy.2020.109774. Epub 2020 Apr 23.
7
P-selectin blockade in COVID-19-related ARDS.新冠病毒相关急性呼吸窘迫综合征中P-选择素的阻断作用
Am J Physiol Lung Cell Mol Physiol. 2020 Jun 1;318(6):L1237-L1238. doi: 10.1152/ajplung.00202.2020.
8
Case 18-2020: A 73-Year-Old Man with Hypoxemic Respiratory Failure and Cardiac Dysfunction.病例18 - 2020：一名患有低氧血症性呼吸衰竭和心脏功能障碍的73岁男性。
N Engl J Med. 2020 Jun 11;382(24):2354-2364. doi: 10.1056/NEJMcpc2002417.
9
Thrombolysis restores perfusion in COVID-19 hypoxia.溶栓治疗可恢复新冠肺炎低氧血症患者的灌注。
Br J Haematol. 2020 Sep;190(5):e270-e274. doi: 10.1111/bjh.17050. Epub 2020 Aug 17.
10
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.治疗新型冠状病毒肺炎低氧血症患者：回归应用生理学
Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. doi: 10.1016/j.accpm.2020.04.003. Epub 2020 Apr 16.
引用本文的文献
1
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trial.静脉注射烯丙哌三嗪对新型冠状病毒肺炎急性低氧性呼吸衰竭患者插管或死亡率的影响：一项多中心、随机、双盲、安慰剂对照试验
EClinicalMedicine. 2022 Oct;52:101663. doi: 10.1016/j.eclinm.2022.101663. Epub 2022 Sep 21.
2
Aromatic or Hetero-aromatic Directly Attached Tri and Tetrasubstituted Methanes: New Chemical Entities as Anti-Infectives.芳族或杂芳族直接连接的三取代和四取代甲烷：作为抗感染剂的新化学实体。
Curr Med Chem. 2023;30(8):974-998. doi: 10.2174/0929867329666220823111812.
3
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury.急性呼吸窘迫综合征和 COVID-19 肺损伤的病理生理学。
Crit Care Clin. 2021 Oct;37(4):749-776. doi: 10.1016/j.ccc.2021.05.003. Epub 2021 May 28.
4
The Pathophysiology and Dangers of Silent Hypoxemia in COVID-19 Lung Injury.新型冠状病毒肺炎肺损伤静默性低氧血症的病理生理学和危险。
Ann Am Thorac Soc. 2021 Jul;18(7):1098-1105. doi: 10.1513/AnnalsATS.202011-1376CME.
本文引用的文献
1
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.血管内皮：严重 SARS-CoV-2 感染导致器官功能障碍的基石。
Crit Care. 2020 Jun 16;24(1):353. doi: 10.1186/s13054-020-03062-7.
2
Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome.烯丙哌三嗪治疗新型冠状病毒2型急性呼吸窘迫综合征低氧血症的疗效
Chest. 2020 Nov;158(5):2003-2006. doi: 10.1016/j.chest.2020.05.573. Epub 2020 Jun 6.
3
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.阿米三嗪作为一种改善新冠肺炎患者肺内分流的非通气策略。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. doi: 10.1016/j.accpm.2020.05.013. Epub 2020 Jun 4.
4
Effect of almitrine bismesylate and inhaled nitric oxide on oxygenation in COVID-19 acute respiratory distress syndrome.二甲磺酸阿米三嗪与吸入一氧化氮对新型冠状病毒肺炎急性呼吸窘迫综合征氧合的影响
Anaesth Crit Care Pain Med. 2020 Aug;39(4):471-472. doi: 10.1016/j.accpm.2020.05.014. Epub 2020 Jun 4.
5
Management of COVID-19 Respiratory Distress.新型冠状病毒肺炎呼吸窘迫的管理
JAMA. 2020 Jun 9;323(22):2329-2330. doi: 10.1001/jama.2020.6825.
6
Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology.治疗新型冠状病毒肺炎低氧血症患者：回归应用生理学
Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. doi: 10.1016/j.accpm.2020.04.003. Epub 2020 Apr 16.
7
Basing Respiratory Management of COVID-19 on Physiological Principles.基于生理原理进行新型冠状病毒肺炎的呼吸管理
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1319-1320. doi: 10.1164/rccm.202004-1076ED.
8
COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome.新冠病毒肺炎不会导致“典型的”急性呼吸窘迫综合征。
Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. doi: 10.1164/rccm.202003-0817LE.
9
Hypoxic pulmonary vasoconstriction: physiology and anesthetic implications.低氧性肺血管收缩：生理学与麻醉学意义。
Anesthesiology. 2015 Apr;122(4):932-46. doi: 10.1097/ALN.0000000000000569.
10
Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure.医学中的生理学：急性呼吸衰竭期间低氧性肺血管收缩在维持动脉氧合中的重要性。
Crit Care. 2001;5(2):67-71. doi: 10.1186/cc989. Epub 2001 Mar 6.
Zotero 插件